CD45 anticorps (FITC)
(1 reference)Aperçu rapide pour CD45 anticorps (FITC) (ABIN135537)
Antigène
Voir toutes CD45 (PTPRC) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Chicken CD45, Mr 190-215 kDa
-
Attributs du produit
- Mouse Anti-Chicken CD45-FITC
-
Immunogène
- Chicken bursal lymphocytes
-
Isotype
- IgM
-
-
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) antibody
PTPRC Reactivité: Humain FACS, IHC, WB, IF Hôte: Souris Monoclonal 2B11-PD7-26 unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 371-556) antibodyPTPRC Reactivité: Souris IHC, WB, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 193-575) antibodyPTPRC Reactivité: Humain IHC, WB, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) antibodyPTPRC Reactivité: Humain FACS, IHC, WB, IF Hôte: Lapin Monoclonal PTPRC-2877R unconjugated Recombinant Antibody
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (C-Term) antibodyPTPRC Reactivité: Humain FACS, IHC, WB, IP, ICC, IF (p) Hôte: Lapin Monoclonal BL-178-12C7 unconjugated Recombinant Antibody
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 24-575) antibodyPTPRC Reactivité: Humain FACS, IHC, WB, IF, ELISA Hôte: Souris Monoclonal 17H9D4 unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (C-Term) antibodyPTPRC Reactivité: Humain, Souris, Rat, Chien, Poulet, Boeuf (Vache), Cat, Lapin, Mouton, Cobaye, Porc, Chévre, Singe, Cheval, Avian, Âne, Hamster WB, IHC (p), IHC (fro) Hôte: Chèvre Polyclonal unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 928-989) antibodyPTPRC Reactivité: Humain IHC, ELISA Hôte: Souris Monoclonal 5D3A3 unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 431-577) antibodyPTPRC Reactivité: Humain FACS, IHC, ELISA Hôte: Souris Monoclonal 1B9B10 unconjugated
anti-Protein tyrosine Phosphatase, Receptor Type, C (PTPRC) (AA 378-577) antibodyPTPRC Reactivité: Humain, Souris, Rat FACS, IHC, WB, ELISA, ICC Hôte: Souris Monoclonal 2H3E2 unconjugated
-
-
Indications d'application
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , IHC-PS - Reported in literature , IHC-WM - Reported in literature , ICC - Reported in literature , IP - Reported in literature , Sep - Reported in literature
- Working Dilutions: Flow Cytometry FITC, BIOT, and AF488 conjugates 1 g/106 cells PE, APC, and SPRD conjugates 0.2 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Volume d'échantillon
- 1 mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.5 mg in 1.0 mL of PBS/Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C
-
-
-
: "Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge." dans: Vaccine, (2010) (PubMed).
-
-
- CD45 (PTPRC) (Protein tyrosine Phosphatase, Receptor Type, C (PTPRC))
-
Autre désignation
- CD45
-
Sujet
- Chicken CD45 is a transmembrane glycoprotein expressed on all leukocytes. B lineage cells in the bursa of Fabricius express the 215 kDa isoform while T lineage cells bear the 190 kDa variant. These high molecular weight molecules have intrinsic phosphotyrosine phosphatase activity characteristic of mammalian CD45.1 Levels of CD45 expression detected by MAb LT40 in the avian thymus are heterogeneous with approximately 90 % of thymocytes expressing fourfold higher levels of surface CD45 (CD45hi) than do the remaining 10 % (CD45lo) of thymocytes. The CD45lo population contains exclusively thymocytes with the CD3-CD4-CD8lo phenotype characteristic of the immediate precursors to the CD3-CD4+CD8+ thymic population which are CD45hi. This shift from low to high levels of surface CD45 expression is concomitant with the transition from CD4-CD8lo to CD4+CD8+ and before the expression of CD3.
-
Pathways
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, BCR Signaling
Antigène
-
